| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 03/30/1995 | WO1995008343A1 Modified truncated complement system regulators |
| 03/29/1995 | EP0645398A1 Method of crystallizing n?2 -((s)-1-ethoxycarbonyl-3-phenylpropyl)-n?6 -trifluoroacetyl-l-lysyl-l-proline |
| 03/29/1995 | EP0645397A1 Glutathione analogs and paralog panels comprising glutathione mimics |
| 03/29/1995 | EP0644892A1 Inhibitors of angiotensin i chymase(s) including human heart chymase |
| 03/29/1995 | EP0644890A1 Oligonucleotide-polyamide conjugates |
| 03/29/1995 | EP0644772A1 Opioid peptides |
| 03/29/1995 | EP0472670B1 Symmetrical bipeptides including a polyalkylene-gylcol group, method of preparation and use in protease determination |
| 03/28/1995 | US5401766 Aminoacid derivatives, a process for their preparation, agents containing these compounds, and the use thereof |
| 03/28/1995 | US5401722 Peptide analogues |
| 03/28/1995 | US5401535 Precious metal composition |
| 03/23/1995 | WO1995008115A1 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen |
| 03/23/1995 | WO1995007928A1 Process for purifying 1-[n2-((s)-ethoxycarbonyl)-3-phenylpropyl)-n6-trifluoroacetyl]-l-lysyl-l-proline (lisinopril(tfa)ethyl ester) |
| 03/22/1995 | EP0644198A1 Alpha-heteroaryloxymethyl ketones as interleukin-1beta converting enzyme inhibitors |
| 03/22/1995 | EP0644197A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors |
| 03/22/1995 | EP0644181A1 Amino acid derivative and use thereof |
| 03/22/1995 | EP0527803B1 Composition for macrophage activation |
| 03/22/1995 | EP0495877B1 Methods and compositions for healing bone |
| 03/22/1995 | CN1100426A Lysosomal enzyme-cleavable antitumor drug conjugates |
| 03/22/1995 | CN1100413A Urethanes and ureas that induce cytokine production |
| 03/21/1995 | US5399741 DNA gyrase inhibitors, process for their manufacture and pharmaceutical preparations containing same |
| 03/21/1995 | US5399570 Aspartic acid derivatives, and their use for inhibiting platelete aggregation |
| 03/21/1995 | US5399487 6-peptidylamino-1-naphthalenesulfonamides useful as fluorogenic proteolytic enzyme substrates |
| 03/16/1995 | WO1995007292A1 Antibiotics 10381v, w, x, y, z1, z2, pre-b and t |
| 03/16/1995 | WO1995007291A1 Kininogen inhibitors |
| 03/16/1995 | WO1995007269A1 Polar-substituted hydrocarbons |
| 03/16/1995 | WO1995007261A1 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use |
| 03/16/1995 | WO1995007257A1 Difluoro statone antiviral analogs |
| 03/16/1995 | WO1995007093A1 Method for design of substances that enhance memory and improve the qualilty of life |
| 03/16/1995 | CA2171471A1 Polar-substituted hydrocarbons |
| 03/16/1995 | CA2170896A1 Kininogen inhibitors |
| 03/16/1995 | CA2170648A1 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use |
| 03/16/1995 | CA2168561A1 Antibiotics 10381v, w, x, y, z1, z2, pre-b and t |
| 03/16/1995 | CA2148452A1 Method for design of substances that enhance memory and improve the quality of life |
| 03/15/1995 | EP0643073A1 Tripeptide antithrombotic agents |
| 03/15/1995 | EP0643072A1 2-Piperazinone compounds and their use |
| 03/15/1995 | EP0643047A1 1(2-amino-5-(1-(triphenylmethyl)-1H-imidazol-4-yl)-1-oxopentyl)piperidine derivatives, their preparation and their use as synthetic intermediates |
| 03/15/1995 | EP0642823A1 Process and apparatus for recovery of raw materials in the aspartame preparation process |
| 03/15/1995 | EP0642530A1 Derivatives of dolastatin |
| 03/15/1995 | EP0472671B1 PEPTIDE SUBSTRATES FOR Xa FACTOR IDENTIFICATION |
| 03/15/1995 | CN1100143A Enzymatic piperidine-2-alkyl-carboxlate and application of products therefrom |
| 03/15/1995 | CA2131963A1 1-¬2-amino-5-¬1-(triphenylmethyl)-1h-imidazol-4-yl|-1-oxopentyl|piperidine derivatives; process for preparing the same and their use as synthesis intermediates |
| 03/15/1995 | CA2131759A1 Valine-containing pseudopeptides with antiviral activity |
| 03/15/1995 | CA2131758A1 Pseudopeptides with antiviral activity |
| 03/14/1995 | US5397796 Inhibitors of platelet aggregation, metastasis of carcinoma cells and osteoclast binding to the bone surfaces |
| 03/14/1995 | CA2131760A1 Nucleic acid-binding oligomers possessing c-branching for therapy and diagnostics |
| 03/14/1995 | CA2131755A1 Nucleic acid-binding oligomers possessing n-branching for therapy and diagnostics |
| 03/09/1995 | WO1995006654A1 Glycosyl amides of 2-aminoacylamino-2-deoxy sugars |
| 03/09/1995 | WO1995006477A1 Inhibition of beta amyloid binding to glycosaminoglycans for treatment of alzheimer's disease |
| 03/09/1995 | CA2170395A1 Glycosyl amides of 2-aminoacylamino-2-deoxy sugars |
| 03/09/1995 | CA2131639A1 Thioglycerol derivatives |
| 03/08/1995 | EP0641800A1 Lactol derivatives as inhibiters of cathepsin L |
| 03/08/1995 | EP0641776A2 Thioglycerol derivatives |
| 03/08/1995 | EP0641325A1 Retroviral protease inhibitors |
| 03/08/1995 | EP0641222A1 TECHNETIUM-99m LABELED PEPTIDES FOR THROMBUS IMAGING |
| 03/08/1995 | EP0495013B1 Hexapeptides with sulphate ester groups |
| 03/08/1995 | CN1099759A 哌嗪衍生物 Piperazine derivatives |
| 03/08/1995 | CN1027812C Process for preparing sweetener of l-asparaginic acid or L-glutamic acid |
| 03/07/1995 | US5395609 Synthetic peptides for use in tumor detection |
| 03/07/1995 | US5395594 Simultaneous multiple chemical synthesizer |
| 03/04/1995 | CA2131397A1 Lactol derivatives, their production and use |
| 03/02/1995 | WO1995006061A1 Retroviral protease inhibitors and combinations thereof |
| 03/02/1995 | WO1995006060A1 Peptide compound |
| 03/02/1995 | WO1995006031A1 Inhibitors of tnf-alpha secretion |
| 03/02/1995 | WO1995006030A1 Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors |
| 03/02/1995 | WO1995005841A1 Novel tripeptides useful in immune and cns therapy |
| 03/02/1995 | CA2170158A1 Inhibitors of tnf-alpha secretion |
| 03/02/1995 | CA2169072A1 Novel tripeptides useful in immune and cns therapy |
| 03/01/1995 | EP0640618A1 Tetrahydronaphthalene-peptide derivatives |
| 03/01/1995 | EP0640617A1 Substituted azepino (2,1-a)isoquinoline compounds |
| 03/01/1995 | EP0640099A1 Peptides having tachykinin antagonist activity |
| 03/01/1995 | EP0640086A1 NOVEL MERCAPTOACETYLAMIDO PYRIDAZO 1,2]PYRIDAZINE, PYRAZOLO 1,2]PYRIDAZINE, PYRIDAZO 1,2-a] 1,2]DIAZEPINE AND PYRAZOLO 1,2-a] 1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE |
| 03/01/1995 | EP0518908B1 Method for polymerization of epoxide compounds |
| 03/01/1995 | EP0469102B1 Novel peptide substrates, method of preparation and use in c protein determination |
| 03/01/1995 | EP0406428B1 Peptide derivatives and their use |
| 03/01/1995 | CN1099392A Compounds containing a fused bicyclic ring and processes therefor |
| 02/28/1995 | US5393915 Method of preparing α-L-aspartyl-L-phenylalanine methyl ester or its hydrochloride salt |
| 02/28/1995 | US5393740 Neurotensin Hexapeptides |
| 02/28/1995 | CA1334589C Benzodiazepine derivatives |
| 02/27/1995 | CA2130793A1 Heterocyclic thrombin inhibitors |
| 02/23/1995 | WO1995005192A1 SUBSTITUTED KETONE DERIVATIVES AS INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 02/23/1995 | WO1995005191A1 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF-β ACTIVITY |
| 02/23/1995 | CA2169360A1 Methods and compositions for stimulating and inhibiting tgf-.beta. activity |
| 02/22/1995 | EP0639586A1 Phosphonic acid derivatives, process for their preparation and pharmaceutical compositions comprising them |
| 02/22/1995 | EP0639585A1 Elastase inhibitor |
| 02/22/1995 | EP0639202A1 Stable polypeptide composition |
| 02/21/1995 | US5391810 Method of crystallizing α-L-aspartyl-L-phenylalanine methyl ester |
| 02/21/1995 | US5391809 Treating N-formyl-alpha-aspartylphenylalanine derivative with mixed solvent of methanol, hydrochloric acid and water under reduced pressure |
| 02/21/1995 | US5391763 3-aza-bicyclo[3.1.0]hexanes which are intermediates for anti-bacterial azabicyclo quinolone carboxylic acids |
| 02/21/1995 | US5391705 Polyfluorinated tripeptide thrombin inhibitors |
| 02/21/1995 | US5391486 Physiologically active substance BE-16627 |
| 02/21/1995 | CA2130279A1 Elastase inhibitor |
| 02/16/1995 | WO1995004752A1 Therapeutic peptide derivatives |
| 02/16/1995 | WO1995004751A1 Selectin binding glycopeptides |
| 02/16/1995 | WO1995004718A1 4-methyleneproline derivatives as fungicides |
| 02/16/1995 | CA2168454A1 Selectin binding glycopeptides |
| 02/15/1995 | EP0638588A1 Derivatives of 6,7-Dihydroxy-4-thiaheptonic acid and their use |
| 02/15/1995 | EP0573538B1 Peptides for treatment |
| 02/15/1995 | EP0339046B1 Leukotriene b 4 analogs |
| 02/15/1995 | CN1027640C Process for the production of new trifluoromethyl ketone substituted peptide derivatives |
| 02/14/1995 | US5389628 Amino and nitro containing tricyclic compounds useful as inhibitors of ace |